Authors:
VIDALSICART S
PONS F
PIULACHS J
CASTEL T
PALOU J
HERRANZ R
Citation: S. Vidalsicart et al., MIDARM SENTINEL LYMPH-NODES SHOWING SURPRISING DRAINAGE FROM A MALIGNANT-MELANOMA IN THE FOREARM, Clinical nuclear medicine, 23(5), 1998, pp. 273-274
Authors:
BARJOSEPH G
WEINBERGER T
CASTEL T
BARJOSEPH N
LAOR A
BURSZTEIN S
BENHAIM S
Citation: G. Barjoseph et al., COMPARISON OF SODIUM-BICARBONATE, CARBICARB, AND THAM DURING CARDIOPULMONARY-RESUSCITATION IN DOGS, Critical care medicine, 26(8), 1998, pp. 1397-1408
Authors:
PUIG S
MALVEHY J
RUIZ A
LAZARO C
VOLPINI V
CARDELLACH F
LECHA M
ESTIVILL X
CASTEL T
Citation: S. Puig et al., INCIDENCE OF CDKN2A MUTATIONS IN MELANOMA FAMILIES - INHERITED SUSCEPTIBILITY TO SEVERAL CANCERS BUT NOT ALWAYS ASSOCIATION WITH DYSPLASTICNEVUS SYNDROME, Journal of investigative dermatology, 110(4), 1998, pp. 617-617
Authors:
RUIZ A
PUIG S
LYNCH M
CASTEL T
ESTIVILL X
Citation: A. Ruiz et al., RETENTION OF THE CDKN2A LOCUS AND LOW-FREQUENCY OF POINT MUTATIONS INPRIMARY AND METASTATIC CUTANEOUS MALIGNANT-MELANOMA, International journal of cancer, 76(3), 1998, pp. 312-316
Authors:
PUIG S
RUIZ A
CASTEL T
VOLPINI V
MALVEHY J
CARDELLACH F
LYNCH M
MASCARO JM
ESTIVILL X
Citation: S. Puig et al., INHERITED SUSCEPTIBILITY TO SEVERAL CANCERS BUT ABSENCE OF LINKAGE BETWEEN DYSPLASTIC NEVUS SYNDROME AND CDKN2A IN A MELANOMA FAMILY WITH AMUTATION IN THE CDKN2A (P16INK4A) GENE, Human genetics, 101(3), 1997, pp. 359-364
Authors:
MORAL A
PALOU J
LAFUENTE A
MOLINA R
PIULACHS J
CASTEL T
TRIAS M
MASCARO JM
VILALTA A
BALLESTA A
MOLINA T
ESTIVILL X
ESTAPE J
Citation: A. Moral et al., IMMUNOHISTOCHEMICAL STUDY OF ALPHA-CLASS, MU-CLASS AND PI-CLASS GLUTATHIONE-S-TRANSFERASE EXPRESSION IN MALIGNANT-MELANOMA, British journal of dermatology, 136(3), 1997, pp. 345-350
Authors:
MELLADO B
COLOMER D
CASTEL T
MUNOZ M
CARBALLO E
GALAN M
MASCARO JM
VIVESCORRONS JL
GRAU JJ
ESTAPE J
Citation: B. Mellado et al., DETECTION OF CIRCULATING NEOPLASTIC-CELLS BY REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION IN MALIGNANT-MELANOMA - ASSOCIATION WITH CLINICAL STAGE AND PROGNOSIS, Journal of clinical oncology, 14(7), 1996, pp. 2091-2097
Authors:
PUIG S
MALVEHI J
ASCASO C
PALOU J
VENTURA P
CASTEL T
MASCARO JM
Citation: S. Puig et al., CLINICOPATHOLOGICAL CHARACTERIZATION OF ATYPICAL MOLES - A NOVEL ATYPICAL MOLE FREQUENT IN THE SOUTH EUROPEAN POPULATION, Journal of investigative dermatology, 106(4), 1996, pp. 507-507
Authors:
PUIG S
RUIZ A
LAZARO C
CASTEL T
LYNCH M
PALOU J
VILALTA A
WEISSENBACH J
MASCARO JM
ESTIVILL X
Citation: S. Puig et al., CHROMOSOME 9P DELETIONS IN MELANOMA TUMORS AND LACK OF INVOLVEMENT OFP16 (CKDN2) IN EARLY DEVELOPMENT OF CUTANEOUS MALIGNANT-MELANOMA, Journal of investigative dermatology, 104(4), 1995, pp. 584-584
Authors:
LAFUENTE A
MOLINA R
PALOU J
CASTEL T
MORAL A
TRIAS M
MASCARO JM
VILALTA A
TRIAS M
PIULACHS J
BALLESTA A
ESTIVILL X
ESTAPE J
Citation: A. Lafuente et al., PHENOTYPE OF GLUTATHIONE-S-TRANSFERASE MU (GSTM1) AND SUSCEPTIBILITY TO MALIGNANT-MELANOMA, British Journal of Cancer, 72(2), 1995, pp. 324-326
Authors:
LYNCH M
RUIZ A
PUIG S
LAZARO C
CASTEL T
ESTIVILL X
Citation: M. Lynch et al., P16 (CDKN2) IS COMMONLY MUTATED IN MELANOMA PREDISPOSED PATIENTS, BUTRARELY IN MELANOMA TUMORS, American journal of human genetics, 57(4), 1995, pp. 381-381
Authors:
PUIG S
RUIZ A
LAZARO C
CASTEL T
LYNCH M
PALOU J
VILALTA A
WEISSENBACH J
MASCARO JM
ESTIVILL X
Citation: S. Puig et al., CHROMOSOME 9P DELETIONS IN CUTANEOUS MALIGNANT-MELANOMA TUMORS - THE MINIMAL DELETED REGION INVOLVES MARKERS OUTSIDE THE P16 (CDKN2) GENE, American journal of human genetics, 57(2), 1995, pp. 395-402